The PPRC is a network of university-based experts in pharmaceutical policy. We collaborate to produce and communicate research on issues that matter to Canadians.

Featured Research

Primary medication non-adherence after discharge from a general internal medicine service

This study finds that primary non-adherence – failure to fill an initial prescription -- during hospitalization is common, and more likely to occur in patients discharged from a nursing home.

Irfan Dhalla
PLoS ONE
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0061735
, 2013

Pharmaceutical sales representatives and patient safety: A comparative prospective study of information quality in Canada, France and the United States

This study assess information quality provided by pharmaceutical sales representatives to family physicians in Montreal, Vancouver, Sacramento and Toulouse. In all sites, physicians were rarely informed about serious adverse events.

Barbara MintzesJoel Lexchin
Journal of General Internal Medicine
http://link.springer.com/article/10.1007%2Fs11606-013-2411-7
, 2013

International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companies

Reimbursement contracts present opportunities and challenges to policymakers as they seek to negotiate prices that reflect the true value of new drugs to society.

Steve Morgan
Health Affairs
http://content.healthaffairs.org/content/32/4/771.abstract
, 2013

How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?

This study aimed to shed light on the potential unintended consequences of the current financing arrangement for prescription drugs in Ontario. The results provide some evidence that the relatively small user charges in Ontario affect individuals’ behaviours.

Michael Law
Health Policy
http://www.sciencedirect.com/science/article/pii/S0168851013000626
, 2013

Provincial drug plan officials' views of the Canadian drug safety system

A divide exists between the federal and provincial governments with regard to the availability of pharmaceutical safety and efficacy information. The study interviews drug plan officials to better understand provincial views on the Canadian drug safety system.

Joel Lexchin
Journal of Health Politics, Policy and Law
http://jhppl.dukejournals.org/content/early/2013/02/11/03616878-2079514.full.pdf+html
, 2013
1
2
3
4
5

PPRC News

View all PPRC news

Pharma News

View all Pharma news

Events

View all events